Your Article Summary
See Latest ArticlesUse of antiandrogens as therapy for women with polycystic ovary syndrome
Fertility and Sterility, 08/14/06
Paolo Moghetti M.D., et al - Because androgen excess plays a fundamental role in symptoms and, it is likely, in pathogenesis of polycystic ovary syndrome, attenuation of hyperandrogenism appears to be of paramount importance in the therapy of this condition. Consistently, drugs inhibiting androgen receptor binding not only are an effective tool in hirsutism treatment but also show favorable effects on body composition and metabolic features of these women
Related Articles
Genotype and haplotype determination of interleukin (IL) 1beta and IL-1RN in polycystic ovary syndrome
Fertility and Sterility, 11/12/09
Relevance Score: 82%%
Epigenetics in polycystic ovary syndrome: A pilot study of global DNA methylation
Fertility and Sterility, 12/01/09
Relevance Score: 81%%
Variation in the perilipin gene (PLIN) affects glucose and lipid metabolism in non-Hispanic white women with and without polycystic ovary syndrome
Diabetes Research and Clinical Practice, 11/25/09
Relevance Score: 81%%
Dissociation of endothelial function and arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS)
Clinical Endocrinology, 11/17/09
Relevance Score: 81%%
Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS)
Fertility and Sterility, 11/10/09
Relevance Score: 81%%
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Difference in Insulin Usage Patterns with Pubertal Development in Children with Type 1 Diabetes During Transition from Multiple Daily Injections to Continuous Subcutaneous Insulin Infusion (CSII) and Through the CSII Treatment
Diabetes Technology & Therapeutics, 12/16/09
Responses to Continuous Glucose Monitoring in Subjects with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion or Multiple Daily Injections
Diabetes Technology & Therapeutics, 12/16/09
Metformin Reduces Arterial Stiffness and Improves Endothelial Function in Young Women with Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled, Crossover Trial
Journal of Clinical Endocrinology and Metabolism, 12/16/09
Today in Reproductive Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Metformin Reduces Arterial Stiffness and Improves Endothelial Function in Young Women with Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled, Crossover Trial
Journal of Clinical Endocrinology and Metabolism, 12/16/09
Associations of Birthweight and Gestational Age with Reproductive and Metabolic Phenotypes in Women with Polycystic Ovarian Syndrome and Their First-Degree Relatives
Journal of Clinical Endocrinology and Metabolism, 12/16/09
A new FSHbeta mutation in a 29 year-old woman with primary amenorrhea and isolated FSH deficiency: functional characterization and ovarian response to human recombinant FSH
European Journal of Endocrinology, 12/16/09